BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8712478)

  • 1. Leukocyte flow properties, polymorphonuclear membrane fluidity, and cytosolic Ca2+ content in subjects with vascular atherosclerotic disease with and without noninsulin-dependent diabetes mellitus.
    Caimi G; Canino B; Ferrara F; Montana M; Meli F; Catania A; Lo presti R
    Angiology; 1996 Aug; 47(8):757-63. PubMed ID: 8712478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukocyte flow properties, polymorphonuclear membrane fluidity and cytosolic Ca2+ content in subjects with vascular atherosclerotic disease.
    Caimi G; Lo Presti R; Canino B; Ferrara F; Montana M; Ventimiglia G; Catania A; Cospite M; Sarno A
    Artery; 1997; 22(6):328-35. PubMed ID: 9921407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphonuclear leukocyte membrane fluidity and cytosolic Ca2+ content in different clinical conditions.
    Caimi G; Canino B; Montana M; Ventimiglia G; Catania A; Lo Presti R
    Clin Hemorheol Microcirc; 1997; 17(3):217-23. PubMed ID: 9356786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavior of the polymorphonuclear leukocyte membrane fluidity and cystolic Ca2+ content in vascular atherosclerotic disease with and without non-insulin-dependent diabetes mellitus.
    Caimi G; Canino B; Montana M; Ferrara F; Ventimiglia G; Meli F; Romano A; Catania A; Lo Presti R
    Clin Hemorheol Microcirc; 1997; 17(6):429-36. PubMed ID: 9502527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphonuclear leukocyte: rheology, metabolism and integrin pattern in vascular atherosclerotic disease and in type 2 diabetes mellitus.
    Caimi G; Lo Presti R; Montana M; Carollo C; Amodeo G; Romano A; Canino B
    Clin Hemorheol Microcirc; 2004; 30(3-4):229-35. PubMed ID: 15258348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphonuclear leukocyte membrane fluidity and cytosolic Ca2+ concentration in subjects with vascular atherosclerotic disease subdivided according to its extent.
    Lo Presti R; Tozzi Ciancarelli MG; Canino B; Carollo C; Lucido D; Amodeo G; Romano A; Caimi G
    Clin Hemorheol Microcirc; 2006; 35(1-2):199-201. PubMed ID: 16899927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential hypertension: leukocyte rheology and polymorphonuclear cytosolic Ca2+ content at baseline and after activation.
    Caimi G; Lo Presti R; Canino B; Montana M; Ferrara L; Oddo G; Ventimiglia G; Cerasola G
    Clin Hemorheol Microcirc; 1998 Dec; 19(4):281-9. PubMed ID: 9972665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise test: trend of the leukocyte flow properties, polymorphonuclear membrane fluidity and cytosolic Ca2+ content in normals, in subjects with previous acute myocardial infarction and in subjects with aortocoronary by-pass.
    Caimi G; Assennato P; Canino B; Montana M; Ventimiglia G; Lo Presti R
    Clin Hemorheol Microcirc; 1997; 17(2):127-35. PubMed ID: 9255436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic renal failure: leukocyte rheology and polymorphonuclear cytosolic Ca2+ concentration.
    Lo Presti R; Canino B; Vaccaro F; Montana M; Ventimiglia G; Grifò G; Caimi G
    Curr Med Res Opin; 1999; 15(3):202-7. PubMed ID: 10621927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type II diabetics with macrovascular complications: polymorphonuclear leukocyte (PMN) filtration, PMN membrane fluidity and cytosolic Ca2+ content after activation.
    Caimi G; Lo Presti R; Montana M; Ferrara F; Ventimiglia G; Meli F; Catania A; Canino B
    Horm Metab Res; 1998 Feb; 30(2):72-6. PubMed ID: 9543687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytosolic Ca2+ content and membrane fluidity of platelets and polymorphonuclear leucocytes in diabetes mellitus.
    Caimi G; Lo Presti R; Canino B; Montana M; Ventimiglia G; Catania A; Sarno A
    Horm Metab Res; 1995 Aug; 27(8):352-5. PubMed ID: 7590622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphonuclear leukocyte membrane fluidity and cytosolic Ca2+ concentration in diabetes mellitus.
    Caimi G; Canino B; Montana M; Ventimiglia G; Catania A; Lo Presti R
    Acta Diabetol; 1998 Oct; 35(3):158-60. PubMed ID: 9840453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of the altered polymorphonuclear leukocyte rheological and metabolic variables after 12 months in juvenile myocardial infarction.
    Lo Presti R; Tozzi Ciancarelli MG; Hoffmann E; Incalcaterra E; Canino B; Montana M; D'Amico T; Catania A; Caimi G
    Clin Hemorheol Microcirc; 2006; 35(1-2):227-30. PubMed ID: 16899933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes mellitus: polymorphonuclear leukocyte (PMN) filtration parameters and PMN membrane fluidity after chemotactic activation.
    LoPresti R; Montana M; Canino B; Ventimiglia G; Catania A; Caimi G
    Metabolism; 1999 Jan; 48(1):30-3. PubMed ID: 9920141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphonuclear leukocyte membrane fluidity and cytosolic Ca(2+) content in young adults with acute myocardial infarction. Evaluation at the initial stage and after 12 months.
    Caimi G; Hoffmann E; Canino B; Montana M; Dispensa F; Incalcaterra E; Casciolo MF; Catania A; Lo Presti R
    Clin Hemorheol Microcirc; 2004; 31(1):41-7. PubMed ID: 15272152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukocyte rheology before and after chemotactic activation in some venous diseases.
    Caimi G; Canino B; Ferrara F; Montana M; Raimondi F; LoPresti R
    Eur J Vasc Endovasc Surg; 1999 Nov; 18(5):411-6. PubMed ID: 10610829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane fluidity, membrane lipid pattern, and cytosolic Ca2+ content in platelets from a group of type II diabetic patients with macrovascular complications.
    Caimi G; Lo Presti R; Montana M; Canino B; Ventimiglia G; Romano A; Catania A; Sarno A
    Diabetes Care; 1995 Jan; 18(1):60-3. PubMed ID: 7698049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythrocyte membrane fluidity and red cell cytosolic Ca2+ content during incubation, in normals and in subjects with vascular atherosclerotic disease and non-insulin-dependent diabetes mellitus.
    Caimi G; Canino B; Montana M; Lo Presti R
    Clin Hemorheol Microcirc; 1998 Jul; 18(2-3):195-7. PubMed ID: 9699042
    [No Abstract]   [Full Text] [Related]  

  • 19. Deep venous thrombosis: leukocyte rheology at baseline and after in vitro activation.
    LoPresti R; Ferrara F; Canino B; Montana M; Caimi G
    Haemostasis; 2000; 30(4):168-73. PubMed ID: 11155035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythrocyte individual phospholipids and erythrocyte membrane fluidity in subjects with vascular atherosclerotic disease with and without diabetes mellitus of type 2.
    Caimi G; Serra A; Catania A; D'Asaro S; Montana M; Lo Presti R; Sarno A
    Microcirc Endothelium Lymphatics; 1990; 6(2-3):149-57. PubMed ID: 2247023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.